Jonathan Coles

Has grant

Professor and Honorary Consultant

University of Cambridge
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Jonathan Coles is a faculty member at the University of Cambridge, United Kingdom. As an Honorary Consultant, he specializes in neurotrauma and traumatic brain injury, focusing on cerebral metabolic derangements and connectivity issues in affected patients. His recent research includes studies on glucose metabolism following brain injuries, the impact of amyloid-β and tau deposition on cognitive decline, and guidelines for temperature management in stroke patients.

Recent Grants

Grant: Close

International Collaboration On Neuroinflammation in Traumatic Brain Injury (ICON-TBI)

Open Date: 2017-03-31

Close Date: 2022-10-31

Grant: Close

MICA: Detecting ictogenicity and epileptogenesis

Open Date: 2015-03-01

Close Date: 2020-02-29

Grant: Close

MICA: Training and Novel Probes Programme in PET Neurochemistry - PET Call

Open Date: 2013-12-01

Close Date: 2018-11-30

Grant: Close

Collaborative European NeuroTrauma Effectiveness Research in TBI

Open Date: 2013-10-01

Close Date: 2020-03-31

Grant: Close

Imaging mechanisms of energy failure following head injury.

Open Date: 2011-03-01

Close Date: 2013-02-28

Articles (17)

Traumatic brain injury (TBI) is a major public health concern with significant consequences across various domains. Following the primary event, secondary injuries compound the outcome after TBI, with disrupted glucose metabolism emerging as a relevant factor. This narrative review summarises the existing literature on post-TBI alterations in glucose metabolism. After TBI, the brain undergoes dynamic changes in brain glucose transport, including alterations in glucose transporters and kinetics, and disruptions in the blood–brain barrier (BBB). In addition, cerebral glucose metabolism transitions from a phase of hyperglycolysis to hypometabolism, with upregulation of alternative pathways of glycolysis. Future research should further explore optimal, and possibly personalised, glycaemic control targets in TBI patients, with GLP-1 analogues as promising therapeutic candidates. Furthermore, a more fundamental understanding of alterations in the activation of various pathways, such as the polyol and lactate pathway, could hold the key to improving outcomes following TBI.

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Martin Nørgaard

Københavns Universitet

DENMARK
View details

William Stewart

Adjunct Professor

University of Pennsylvania

UNITED STATES
View details

Tilak Das

Cambridge University Hospitals

UNITED KINGDOM
View details

Colm McGinnity

King’s College London

UNITED KINGDOM
View details

Henning Hermanns

Amsterdam UMC Locatie VUmc

NETHERLANDS
View details

Taylor W. Schmitz

-

CANADA
View details

Naomi Thomas

-

UNITED KINGDOM
View details

Peter Bragge

MONASH UNIVERSITY

AUSTRALIA
View details

Jeroen Hermanides

-

NETHERLANDS
View details

David Nelson

Karolinska Institutet

SWEDEN
View details

Veronique De Keyser

Antwerp University Hospital

BELGIUM
View details

Alexander Hammers

King’s College London

UNITED KINGDOM
View details

Carmen Lopez Soto

King's College Hospital NHS Foundation Trust

UNITED KINGDOM
View details

Joukje van der Naalt

neurologist, MD PhD Professor in Neurotraumatology

University Medical Center Groningen

NETHERLANDS
View details

Jussi P. Posti

-

FINLAND
View details

Peter Nestor

Professor of Cogntive Neurology

-

AUSTRALIA
View details

Randeep Mullhi

University Hospitals Birmingham NHS Foundation Trust

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.